Key Takeaway: The article discusses the potential of cannabidiol in inhibiting the mesothelial to mesenchymal transition in experimental pericarditis. However, it lacks detailed findings or specific data to support this claim. The overall content appears to be more of an announcement rather than a comprehensive study or results presentation.
Price reaction · baseline $0.84 (2023-11-15 close) · hit after-hours · 1 other CRDL headline(s) in the window, move may be shared
day 0 close
+0.6%
Market Sentiment Analysis
Full Press Release Details
Investor Resources
Events & Presentations
Press Releases
Analyst Coverage
Stock Information
Filings & Financials
Corporate Governance
FAQ
Contact Us
Investor Resources
Cannabidiol inhibits the mesothelial to mesenchymal transition in experimental pericarditis